Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 325295, 6 pages
http://dx.doi.org/10.1155/2011/325295
Clinical Study

Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons

1Department of Pulmonary Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu-shi, Tokyo 183-8524, Japan
2Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 18-22-3 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan
3The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose-shi, Tokyo 204-8533, Japan

Received 23 May 2010; Accepted 7 July 2010

Academic Editor: Katalin Andrea Wilkinson

Copyright © 2011 Akira Fujita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. CDC, “Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention,” MMWR. Recommendations and Reports, vol. 47, no. RR-20, pp. 1–58, 1998. View at Google Scholar · View at Scopus
  2. H. Yoshikura, “HIV transmission webs: HIV infection trends in Japan in 1989–2004,” Japanese Journal of Infectious Diseases, vol. 58, no. 6, pp. S19–S21, 2005. View at Google Scholar · View at Scopus
  3. CDC, “Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.,” MMWR. Recommendations and Reports, vol. 49, no. RR-6, pp. 1–51, 2000. View at Google Scholar · View at Scopus
  4. T. Mori, T. Yoshiyama, K. Nakata, A. Fujita, and H.. Nagai, “Preventive chemotherapy,” in AIDS- Associated Tuberculosis–Clinical Features and Countermeasures, T. Kimura and T. Mori, Eds., pp. 127–134, JATA, Tokyo, Japan, 2003. View at Google Scholar
  5. R. E. Huebner, M. F. Schein, and J. B. Bass Jr., “The tuberculin skin test,” Clinical Infectious Diseases, vol. 17, no. 6, pp. 968–975, 1993. View at Google Scholar
  6. P. Andersen, M. E. Munk, J. M. Pollock, and T. M. Doherty, “Specific immune-based diagnosis of tuberculosis,” Lancet, vol. 356, no. 9235, pp. 1099–1104, 2000. View at Google Scholar · View at Scopus
  7. G. H. Mazurek, J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon, “Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States,” MMWR. Recommendations and Reports, vol. 54, no. RR-15, pp. 49–55, 2005. View at Google Scholar
  8. Prevention Committee and Japanese Society of Tuberculosis, “Guidelines for the use of QuantiFERON®TB-2G,” Kekkaku, vol. 81, no. 5, pp. 393–397, 2006 (Japanese). View at Google Scholar
  9. J. E. Kaplan, C. Benson, K. H. Holmes, J. T. Brooks, A. Pau, and H. Masur, “Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America,” MMWR. Recommendations and Reports, vol. 58, no. RR-4, pp. 1–207, 2009. View at Google Scholar · View at Scopus
  10. M. Bocchino, B. Bellofiore, A. Matarese, D. Galati, and A. Sanduzzi, “IFN-γ release assays in tuberculosis management in selected high-risk populations,” Expert Review of Molecular Diagnostics, vol. 9, no. 2, pp. 165–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Mori, “Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays,” Journal of Infection and Chemotherapy, vol. 15, no. 3, pp. 143–155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Nagai, Y. Kawabe, H. Ariga et al., “Usefulness of a whole blood interferon gamma assay (QuantiFERON-TB-2G) for detecting tuberculosis infection in HIV-infected persons,” Kekkaku, vol. 82, no. 8, pp. 635–640, 2007 (Japanese). View at Google Scholar · View at Scopus
  13. M. Maeda, N. Asami, and T. Murohashi, “Further studies on the potency of purified protein derivatives of tuberculin (PPD-s). 1st Report: comparison of the potency of three preparations of PPD,” Kekkaku, vol. 35, pp. 563–566, 1960 (Japanese). View at Google Scholar
  14. N. Harada, K. Higuchi, Y. Sekiya, J. Rothel, T. Kitoh, and T. Mori, “Basic characteristics of a novel diagnostic method (QuantiFERON®TB-2G) of latent tuberculosis infection with a use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10,” Kekkaku, vol. 79, no. 12, pp. 725–735, 2004 (Japanese). View at Google Scholar · View at Scopus
  15. M. Pai, K. Dheda, J. Cunningham, F. Scano, and R. O'Brien, “T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward,” Lancet Infectious Diseases, vol. 7, no. 6, pp. 428–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Harboe, T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen, “Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG,” Infection and Immunity, vol. 64, no. 1, pp. 16–22, 1996. View at Google Scholar · View at Scopus
  17. I. Brock, M. Ruhwald, B. Lundgren, H. Westh, L. R. Mathiesen, and P. Ravn, “Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test,” Respiratory Research, vol. 7, article no. 56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. F. Luetkemeyer, E. D. Charlebois, L. L. Flores et al., “Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 7, pp. 737–742, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Aichelburg, A. Rieger, F. Breitenecker et al., “Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-l-infected individuals,” Clinical Infectious Diseases, vol. 48, no. 7, pp. 954–962, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. J. Talati, U. Seybold, B. Humphrey et al., “Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals,” BMC Infectious Diseases, vol. 9, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Harada, K. Higuchi, T. Yoshiyama et al., “Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection,” Journal of Infection, vol. 56, no. 5, pp. 348–353, 2008. View at Publisher · View at Google Scholar · View at Scopus